- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
U.S. Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
24
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
24 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SRPT | US$118.97 | -3.8% | 25.8% | US$11.4b | US$185.10 | PE93.3x | E43.0% | n/a | ||
ALNY | US$245.44 | 0% | 28.5% | US$31.7b | US$299.11 | PS15.1x | E70.3% | n/a | ||
SGEN | US$228.74 | 4.5% | 76.5% | US$43.2b | US$228.91 | PS18.8x | E71.8% | n/a | ||
NBIX | US$135.42 | 6.9% | 5.4% | US$13.7b | US$165.04 | PE35.5x | E30.4% | n/a | ||
KRTX | US$329.83 | 3.3% | 80.7% | US$12.6b | US$326.92 | PS19238.9x | E60.1% | n/a | ||
LLY | US$767.76 | -2.7% | 34.6% | US$682.1b | US$984.05 | PE82.6x | E29.8% | 0.8% | ||
ABBV | US$175.58 | 1.3% | 13.3% | US$303.1b | US$202.54 | PE61.1x | E28.0% | 3.7% | ||
EXAS | US$59.40 | -3.0% | -19.2% | US$11.0b | US$71.86 | PS4.1x | E72.7% | n/a | ||
BMY | US$57.33 | 2.8% | 9.6% | US$116.3b | US$60.91 | PS2.5x | E48.7% | 4.3% | ||
INCY | US$68.84 | 0.4% | 9.5% | US$13.3b | US$79.38 | PE408.3x | E46.9% | n/a | ||
TEVA | US$22.09 | 33.9% | 110.8% | US$24.2b | US$23.48 | PS1.5x | E65.5% | 0% | ||
BGNE | US$176.50 | -1.6% | 0.2% | US$18.8b | US$280.92 | PS5.8x | E73.3% | n/a | ||
VRTX | US$397.27 | -14.3% | -2.0% | US$102.3b | US$498.24 | PS9.6x | E47.2% | n/a | ||
GILD | US$92.57 | 0.8% | 16.2% | US$115.4b | US$98.92 | PE915.6x | E40.7% | 3.3% | ||
NTRA | US$161.88 | -2.8% | 166.1% | US$21.4b | US$167.90 | PS14x | E69.6% | n/a | ||
AVTR | US$21.21 | -5.0% | -7.5% | US$14.3b | US$27.20 | PE46.6x | E36.2% | n/a | ||
ILMN | US$136.02 | -5.5% | -2.8% | US$21.6b | US$163.52 | PS4.9x | E70.4% | 2.3% | ||
MEDP | US$337.28 | -2.5% | 8.2% | US$10.5b | US$347.92 | PE28.6x | E10.8% | n/a | ||
VTRS | US$12.52 | -0.9% | 17.6% | US$14.9b | US$13.45 | PS1x | E51.6% | 3.8% | ||
HZNP | US$116.30 | 0.06% | 82.8% | US$26.6b | US$116.50 | PE60.8x | E16.4% | n/a | ||
MRK | US$98.05 | -3.9% | -9.0% | US$248.0b | US$128.73 | PE20.4x | E16.0% | 3.3% | ||
TECH | US$73.17 | -3.3% | -5.6% | US$11.6b | US$85.25 | PE77.2x | E21.2% | 0.4% | ||
AMGN | US$263.38 | -2.7% | -7.3% | US$140.4b | US$322.43 | PE33.5x | E18.5% | 3.6% | ||
BMRN | US$65.66 | -0.5% | -31.8% | US$12.5b | US$98.08 | PE38.8x | E27.9% | n/a |
Page 1 of 1